Latest News

MMS Announces Expansion of Asia Operations In Hyderabad

HYDERABAD (January 26, 2016) — MMS Holdings Inc. (www.mmsholdings.com) is pleased to announce the opening of a new office in Hyderabad, India.

The company’s Asia headquarters are located in Bangalore, India and the company’s ability to deliver exceptional quality across all of its service offerings has resulted in steady growth for the company.

According to Prasad Koppolu, Vice President for MMS Holdings Inc., “Our clients have come to depend on us to deliver quality across all of our global office locations and India is no exception. Our presence in both Bangalore and Hyderabad will allow MMS to better serve our global client base by providing greater access to the experienced life sciences talent in this region.”

With its cross-functional staff already in place, the Hyderabad center is expected to be fully operational by early spring 2016.

About MMS Holdings Inc.
MMS Holdings Inc. (www.mmsholdings.com) is a global clinical research organization (CRO) that focuses on regulatory submission support for the pharmaceutical and biotech industries. Our strong industry experience and scientific approach to drug development makes us a valuable partner in creating compelling submissions that meet rigorous regulatory standards. MMS’ clients span from top 10 pharma to virtual biotechs, and we support each one with the same standard of excellence. Our core service areas include medical and regulatory writing, biostatistics, clinical programming, data management, clinical development, clinical trial disclosure, regulatory affairs, regulatory submissions and pharmacovigilance. Our mission is to deliver high-quality services, rooted in good science and decades of regulatory experience, that will assist our clients in developing and marketing life-changing therapies, thereby positively affecting patients’ lives worldwide.

Suggested For You

news

April 4th, 2024

MMS Hires Pharmaceutical Industry Veteran James Zee for Global Biometrics Leadership in Europe Amid Strong Regional Growth

news

October 23rd, 2019

MMS Holdings Executive Michelle Gayari Joins Advisory Board of International Nonprofit

news

December 19th, 2018

Michigan SAS Users Group Chooses MMS Global Headquarters for its Q1 Statistical Programming Event

news

August 16th, 2022

Together Trial with EDC Database Designed by MMS Wins Trial of the Year

news

June 7th, 2022

MMS Holdings Announces Partnership with Medidata to Provide Medidata’s Advanced Rave EDC and Decentralized Clinical Trial Solutions to Sponsors

news

May 24th, 2022

MMS Holdings Selects THREAD as Partner of Choice to Deliver Decentralized Clinical Trials

news

November 19th, 2021

Former Astellas VP of Biostatistics Joins MMS as Principal Advisor of Biostatistics

news

July 28th, 2021

Data CRO Expands its Virtual Learning Portfolio

news

July 15th, 2021

Health Data Research UK Selects MMS as Data Services Partner for the International COVID-19 Data Alliance

news

January 29th, 2021

MMS Holdigns Joins DTRA as A Founding Member to Accelerate The Adoption of Patient- Focused

news

May 19th, 2020

University of Michigan School of Information Invites MMS Holdings Executive Kelly J. Hill to Join External Advisory Board

news

March 4th, 2020

MMS Holdings To Debut Datacise Integrated Safety Explorer To Detect Safety Signals